574 related articles for article (PubMed ID: 23720055)
21. Simultaneous disruption of PRC2 and enhancer function underlies histone H3.3-K27M oncogenic activity in human hindbrain neural stem cells.
Brien GL; Bressan RB; Monger C; Gannon D; Lagan E; Doherty AM; Healy E; Neikes H; Fitzpatrick DJ; Deevy O; Grant V; Marqués-Torrejón MA; Alfazema N; Pollard SM; Bracken AP
Nat Genet; 2021 Aug; 53(8):1221-1232. PubMed ID: 34294917
[TBL] [Abstract][Full Text] [Related]
22. BMI1 sustains human glioblastoma multiforme stem cell renewal.
Abdouh M; Facchino S; Chatoo W; Balasingam V; Ferreira J; Bernier G
J Neurosci; 2009 Jul; 29(28):8884-96. PubMed ID: 19605626
[TBL] [Abstract][Full Text] [Related]
23. Not just a writer: PRC2 as a chromatin reader.
Uckelmann M; Davidovich C
Biochem Soc Trans; 2021 Jun; 49(3):1159-1170. PubMed ID: 34060617
[TBL] [Abstract][Full Text] [Related]
24. Ezh2 is required for neural crest-derived cartilage and bone formation.
Schwarz D; Varum S; Zemke M; Schöler A; Baggiolini A; Draganova K; Koseki H; Schübeler D; Sommer L
Development; 2014 Feb; 141(4):867-77. PubMed ID: 24496623
[TBL] [Abstract][Full Text] [Related]
25. A Structural Perspective on Gene Repression by Polycomb Repressive Complex 2.
Liu X
Subcell Biochem; 2021; 96():519-562. PubMed ID: 33252743
[TBL] [Abstract][Full Text] [Related]
26. The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells.
Kim SH; Kim EJ; Hitomi M; Oh SY; Jin X; Jeon HM; Beck S; Jin X; Kim JK; Park CG; Chang SY; Yin J; Kim T; Jeon YJ; Song J; Lim YC; Lathia JD; Nakano I; Kim H
Cell Death Differ; 2015 Sep; 22(9):1517-25. PubMed ID: 25721045
[TBL] [Abstract][Full Text] [Related]
27. Cooperation between the H3K27me3 Chromatin Mark and Non-CG Methylation in Epigenetic Regulation.
Zhou S; Liu X; Zhou C; Zhou Q; Zhao Y; Li G; Zhou DX
Plant Physiol; 2016 Oct; 172(2):1131-1141. PubMed ID: 27535791
[TBL] [Abstract][Full Text] [Related]
28. Polycomb Repressive Complex 2-Mediated Chromatin Repression Guides Effector CD8
Gray SM; Amezquita RA; Guan T; Kleinstein SH; Kaech SM
Immunity; 2017 Apr; 46(4):596-608. PubMed ID: 28410989
[TBL] [Abstract][Full Text] [Related]
29. PRC2.1 and PRC2.2 Synergize to Coordinate H3K27 Trimethylation.
Healy E; Mucha M; Glancy E; Fitzpatrick DJ; Conway E; Neikes HK; Monger C; Van Mierlo G; Baltissen MP; Koseki Y; Vermeulen M; Koseki H; Bracken AP
Mol Cell; 2019 Nov; 76(3):437-452.e6. PubMed ID: 31521505
[TBL] [Abstract][Full Text] [Related]
30. Chromatin landscapes reveal developmentally encoded transcriptional states that define human glioblastoma.
Mack SC; Singh I; Wang X; Hirsch R; Wu Q; Villagomez R; Bernatchez JA; Zhu Z; Gimple RC; Kim LJY; Morton A; Lai S; Qiu Z; Prager BC; Bertrand KC; Mah C; Zhou W; Lee C; Barnett GH; Vogelbaum MA; Sloan AE; Chavez L; Bao S; Scacheri PC; Siqueira-Neto JL; Lin CY; Rich JN
J Exp Med; 2019 May; 216(5):1071-1090. PubMed ID: 30948495
[TBL] [Abstract][Full Text] [Related]
31. Automethylation of PRC2 promotes H3K27 methylation and is impaired in H3K27M pediatric glioma.
Lee CH; Yu JR; Granat J; Saldaña-Meyer R; Andrade J; LeRoy G; Jin Y; Lund P; Stafford JM; Garcia BA; Ueberheide B; Reinberg D
Genes Dev; 2019 Oct; 33(19-20):1428-1440. PubMed ID: 31488577
[TBL] [Abstract][Full Text] [Related]
32. Comparative analyses identify molecular signature of MRI-classified SVZ-associated glioblastoma.
Lin CA; Rhodes CT; Lin C; Phillips JJ; Berger MS
Cell Cycle; 2017 Apr; 16(8):765-775. PubMed ID: 28278055
[TBL] [Abstract][Full Text] [Related]
33. MLL5 Orchestrates a Cancer Self-Renewal State by Repressing the Histone Variant H3.3 and Globally Reorganizing Chromatin.
Gallo M; Coutinho FJ; Vanner RJ; Gayden T; Mack SC; Murison A; Remke M; Li R; Takayama N; Desai K; Lee L; Lan X; Park NI; Barsyte-Lovejoy D; Smil D; Sturm D; Kushida MM; Head R; Cusimano MD; Bernstein M; Clarke ID; Dick JE; Pfister SM; Rich JN; Arrowsmith CH; Taylor MD; Jabado N; Bazett-Jones DP; Lupien M; Dirks PB
Cancer Cell; 2015 Dec; 28(6):715-729. PubMed ID: 26626085
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation of EZH2 by CDK1 and CDK2: a possible regulatory mechanism of transmission of the H3K27me3 epigenetic mark through cell divisions.
Zeng X; Chen S; Huang H
Cell Cycle; 2011 Feb; 10(4):579-83. PubMed ID: 21278485
[TBL] [Abstract][Full Text] [Related]
35. Mediator complex cooperatively regulates transcription of retinoic acid target genes with Polycomb Repressive Complex 2 during neuronal differentiation.
Fukasawa R; Iida S; Tsutsui T; Hirose Y; Ohkuma Y
J Biochem; 2015 Nov; 158(5):373-84. PubMed ID: 26002960
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic silencing of Bim transcription by Spi-1/PU.1 promotes apoptosis resistance in leukaemia.
Ridinger-Saison M; Evanno E; Gallais I; Rimmelé P; Selimoglu-Buet D; Sapharikas E; Moreau-Gachelin F; Guillouf C
Cell Death Differ; 2013 Sep; 20(9):1268-78. PubMed ID: 23852375
[TBL] [Abstract][Full Text] [Related]
37. Methylation by EZH2 activates STAT3 in glioblastoma.
Cancer Discov; 2013 Jul; 3(7):OF21. PubMed ID: 23847365
[TBL] [Abstract][Full Text] [Related]
38. No Significant Cytotoxic Effect of the EZH2 Inhibitor Tazemetostat (EPZ-6438) on Pediatric Glioma Cells with Wildtype Histone 3 or Mutated Histone 3.3.
Wiese M; Schill F; Sturm D; Pfister S; Hulleman E; Johnsen SA; Kramm CM
Klin Padiatr; 2016 Apr; 228(3):113-7. PubMed ID: 27135271
[TBL] [Abstract][Full Text] [Related]
39. Nucleosome-binding activities within JARID2 and EZH1 regulate the function of PRC2 on chromatin.
Son J; Shen SS; Margueron R; Reinberg D
Genes Dev; 2013 Dec; 27(24):2663-77. PubMed ID: 24352422
[TBL] [Abstract][Full Text] [Related]
40. IMITATION SWITCH is required for normal chromatin structure and gene repression in PRC2 target domains.
Kamei M; Ameri AJ; Ferraro AR; Bar-Peled Y; Zhao F; Ethridge CL; Lail K; Amirebrahimi M; Lipzen A; Ng V; Grigoriev IV; Schmitz RJ; Liu Y; Lewis ZA
Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33468665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
